Trefoil factor 3 promotes pancreatic carcinoma progression via WNT pathway activation mediated by enhanced WNT ligand expression
出版年份 2022 全文链接
标题
Trefoil factor 3 promotes pancreatic carcinoma progression via WNT pathway activation mediated by enhanced WNT ligand expression
作者
关键词
-
出版物
Cell Death & Disease
Volume 13, Issue 3, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-03-25
DOI
10.1038/s41419-022-04700-4
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- FDA Approval Summary: Sotorasib for KRAS G12C-Mutated Metastatic NSCLC
- (2021) Erica C. Nakajima et al. CLINICAL CANCER RESEARCH
- m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling
- (2020) Bo Tang et al. Molecular Cancer
- Phase 1b study of Wnt inhibitor ipafricept (IPA) with gemcitabine and nab-paclitaxel in patients with previously untreated stage IV pancreatic cancer (mPDAC).
- (2020) Efrat Dotan et al. CLINICAL CANCER RESEARCH
- Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer
- (2019) Rahat Jahan et al. EBioMedicine
- USP21 deubiquitinase promotes pancreas cancer cell stemness via Wnt pathway activation
- (2019) Pingping Hou et al. GENES & DEVELOPMENT
- RGDV-modified gemcitabine: a nano-medicine capable of prolonging half-life, overcoming resistance and eliminating bone marrow toxicity of gemcitabine
- (2019) Wenchao Liu et al. International Journal of Nanomedicine
- ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancer
- (2019) Praneeth R. Kuninty et al. Science Advances
- CD9 identifies pancreatic cancer stem cells and modulates glutamine metabolism to fuel tumour growth
- (2019) Victoria M.-Y. Wang et al. NATURE CELL BIOLOGY
- TFF3 interacts with LINGO2 to regulate EGFR activation for protection against colitis and gastrointestinal helminths
- (2019) Nicole Maloney Belle et al. Nature Communications
- Inhibition of TFF3 Enhances Sensitivity—and Overcomes Acquired Resistance—to Doxorubicin in Estrogen Receptor-Positive Mammary Carcinoma
- (2019) Han Poh et al. Cancers
- Pharmacological Inhibition of TFF3 Enhances Sensitivity of CMS4 Colorectal Carcinoma to 5-Fluorouracil through Inhibition of p44/42 MAPK
- (2019) Ru-Mei Chen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors
- (2018) Nithya Krishnamurthy et al. CANCER TREATMENT REVIEWS
- USP9X inhibition improves gemcitabine sensitivity in pancreatic cancer by inhibiting autophagy
- (2018) Tao Ma et al. CANCER LETTERS
- Functionally specific optogenetic modulation in primate visual cortex
- (2018) Mykyta M. Chernov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prognostic Value of Trefoil Factor 3 Expression in Patients with Gastric Cancer
- (2018) Yoshiki Taniguchi et al. WORLD JOURNAL OF SURGERY
- Hypoxia potentiates gemcitabine-induced stemness in pancreatic cancer cells through AKT/Notch1 signaling
- (2018) Zhengle Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Expression of two non-mutated genetic elements is sufficient to stimulate oncogenic transformation of human mammary epithelial cells
- (2018) Vijay Pandey et al. Cell Death & Disease
- WNT signalling in prostate cancer
- (2017) Virginia Murillo-Garzón et al. Nature Reviews Urology
- Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancers
- (2017) Chaoyang Sun et al. Science Translational Medicine
- Expression of trefoil factors and TWIST1 in colorectal cancer and their correlation with metastatic potential and prognosis
- (2017) Akram Yusup et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma
- (2017) Qing-Yun Chong et al. Oncotarget
- Trefoil factor 3 mediation of oncogenicity and chemoresistance in hepatocellular carcinoma is AKT-BCL-2 dependent
- (2017) Ming-Liang You et al. Oncotarget
- Hypomethylation associated enhanced transcription of trefoil factor-3 mediates tamoxifen-stimulated oncogenicity of ER+ endometrial carcinoma cells
- (2017) Vijay Pandey et al. Oncotarget
- Endocrine Therapy of Estrogen Receptor-Positive Breast Cancer Cells: Early Differential Effects on Stem Cell Markers
- (2017) Euphemia Y. Leung et al. Frontiers in Oncology
- SIRT1 promotes epithelial–mesenchymal transition and metastasis in colorectal cancer by regulating Fra-1 expression
- (2016) Feifei Cheng et al. CANCER LETTERS
- Pancreatic cancer
- (2016) Jorg Kleeff et al. Nature Reviews Disease Primers
- Gene expression alterations associated with outcome in aromatase inhibitor-treated ER+ early-stage breast cancer patients
- (2015) Karina G. Thomsen et al. BREAST CANCER RESEARCH AND TREATMENT
- Trefoil factor 3 (TFF3) enhances the oncogenic characteristics of prostate carcinoma cells and reduces sensitivity to ionising radiation
- (2015) Omesha Perera et al. CANCER LETTERS
- TFF3 is a valuable predictive biomarker of endocrine response in metastatic breast cancer
- (2015) F. E. B. May et al. ENDOCRINE-RELATED CANCER
- Trefoil Factor 3 as a Novel Biomarker to Distinguish Between Adenocarcinoma and Squamous Cell Carcinoma
- (2015) Xiao-Nan Wang et al. MEDICINE
- Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
- (2015) Agnieszka K. Witkiewicz et al. Nature Communications
- Trefoil Factor-3 (TFF3) Stimulates De Novo Angiogenesis in Mammary Carcinoma both Directly and Indirectly via IL-8/CXCR2
- (2015) Wai-Hoe Lau et al. PLoS One
- Trefoil Factor 3 Is Oncogenic and Mediates Anti-Estrogen Resistance in Human Mammary Carcinoma
- (2015) Nagarajan Kannan et al. NEOPLASIA
- The value of trefoil factor 3 expression in predicting the long-term outcome and early recurrence of colorectal cancer
- (2014) KIYOTO MORITO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Impact of NPM, TFF3 and TACC1 on the Prognosis of Patients with Primary Gastric Cancer
- (2013) Aiping Ding et al. PLoS One
- TFF3 and survivin expressions associate with a lower survival rate in gastric cancer
- (2012) Jia-Rong Meng et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Animal Research: Reporting in vivo Experiments—The ARRIVE Guidelines
- (2011) Carol Kilkenny et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Signal Transducer and Activator of Transcription (STAT)-5A and STAT5B Differentially Regulate Human Mammary Carcinoma Cell Behavior
- (2009) Jian-Zhong Tang et al. ENDOCRINOLOGY
- Trefoil Factor 3 Stimulates Human and Rodent Pancreatic Islet β-Cell Replication with Retention of Function
- (2008) Patrick T. Fueger et al. MOLECULAR ENDOCRINOLOGY
- Are trefoil factors oncogenic?
- (2007) Jo K. Perry et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search